Management strategies for poor peripheral blood stem cell mobilization.
about
Guideline on the clinical use of apheresis procedures for the treatment of patients and collection of cellular therapy products. British Committee for Standards in Haematology.How we manage autologous stem cell transplantation for patients with multiple myelomaThe ins and outs of hematopoietic stem cells: studies to improve transplantation outcomes.The role of complement in the trafficking of hematopoietic stem/progenitor cells.Effects of short-term pretreatment with atorvastatin on mobilization of hematopoietic progenitor cells: A double-blind, randomized, controlled trial.Bendamustine, etoposide and dexamethasone to mobilize peripheral blood hematopoietic stem cells for autologous transplantation in patients with multiple myelomaAdvances in mobilization for the optimization of autologous stem cell transplantation.Eicosanoid regulation of hematopoiesis and hematopoietic stem and progenitor traffickingThe mobilization of autologous bone marrow stem cells in the treatment of heart failure with Chinese medicine.Blood stem cell products: toward sustainable benchmarks for clinical translation.Large volume leukapheresis is efficient and safe even in small children up to 15 kg body weight.Notch2 blockade enhances hematopoietic stem cell mobilization and homing.Proposed definition of 'poor mobilizer' in lymphoma and multiple myeloma: an analytic hierarchy process by ad hoc working group Gruppo ItalianoTrapianto di Midollo OsseoPlerixafor and Filgrastim XM02 (Tevagastrim) as a first line peripheral blood stem cell mobilisation strategy in patients with multiple myeloma and lymphoma candidated to autologous bone marrow transplantation.Leukapheresis in non-cytokine-stimulated donors with a new apheresis system: first-time collection results and evaluation of subsequent cryopreservation.UK consensus statement on the use of plerixafor to facilitate autologous peripheral blood stem cell collection to support high-dose chemoradiotherapy for patients with malignancy.Peripheral stem cell harvest using regular chemotherapy schedules in childhood cancer.Circulating endothelial cell kinetics and their potential predictive value during mobilization procedure.
P2860
Q33165774-7577F223-DADE-4E70-82B4-417880177725Q34019581-E2DCE850-8E3B-4D6B-9AE0-2E75DBD15F95Q35041174-7F92260B-ED9B-4BC2-9379-BBE8F816FDC2Q36110279-B7E4FC54-E01C-4DBB-8A4B-C2D1B28281C4Q36566280-681E5945-171D-4577-9C1D-B5E5F1AF7076Q37313790-D5979C86-CA8E-426C-BC63-71D31766744FQ37551715-40C8BE5A-2FF2-4FA0-AE61-9CCF2A5C86DAQ37794776-0ABDF42C-C45D-41C0-B819-B63389418252Q37910044-079D5509-49BA-43F3-81D2-2F7863FDE1DDQ38072649-147882F2-CD88-49DA-BC39-FA3F92DA26BCQ42327837-5D08F331-4255-4076-A20C-8FFFC89A9533Q42368326-B20524AF-C39E-4D26-9593-292EBAE016DDQ42592824-21C73D37-A63E-442E-9D9A-EAC0CC295D2AQ44894394-B0CCE6D6-9405-4469-B301-DFC6E883F67FQ47377106-C4081D84-33D5-4FA6-9266-414D2A080D1DQ48251584-68131169-C38D-4F32-8CCB-704C705D8A57Q48413530-249F1226-A771-4426-8D95-EC5CC5F907D9Q50986977-01821FC7-AC7C-403D-AFD2-3FBF342707D5
P2860
Management strategies for poor peripheral blood stem cell mobilization.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 15 May 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Management strategies for poor peripheral blood stem cell mobilization.
@en
Management strategies for poor peripheral blood stem cell mobilization.
@nl
type
label
Management strategies for poor peripheral blood stem cell mobilization.
@en
Management strategies for poor peripheral blood stem cell mobilization.
@nl
prefLabel
Management strategies for poor peripheral blood stem cell mobilization.
@en
Management strategies for poor peripheral blood stem cell mobilization.
@nl
P1476
Management strategies for poor peripheral blood stem cell mobilization.
@en
P2093
Rainer Moog
P304
P356
10.1016/J.TRANSCI.2008.04.002
P577
2008-05-15T00:00:00Z